| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 2565.45 | 98 |
| GSM780708 | Untreated after 4 days (C2_1) | 2334 | 98 |
| GSM780709 | Untreated after 4 days (C3_1) | 2944.38 | 99 |
| GSM780719 | Untreated after 4 days (C1_2) | 2334 | 98 |
| GSM780720 | Untreated after 4 days (C2_2) | 2120.45 | 98 |
| GSM780721 | Untreated after 4 days (C3_2) | 2891.28 | 99 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 2082.06 | 98 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 2005.72 | 98 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 1518.11 | 97 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 2120.45 | 98 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 2038.27 | 98 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1607.38 | 97 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 2307.62 | 98 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 2195.18 | 98 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 2329.34 | 98 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 2207.62 | 98 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 2238.07 | 98 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 2235.83 | 98 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 1757.14 | 98 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1969.44 | 98 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 1877.56 | 98 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 1704.35 | 97 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 2100.45 | 98 |